US2005197280A1PendingUtilityA1
Antioxidant combination composition and use thereof
Est. expiryOct 3, 2021(expired)· nominal 20-yr term from priority
Inventors:Claudio De Simone
A61K 31/195A61K 31/205A61K 31/385A61K 31/355
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An orally or parenterally administrable composition which comprises the following components: (a) L-carnitine inner salt or a pharmacologically acceptable salt thereof, (b) acetyl L-carnitine inner salt or a pharmacologically acceptable salt thereof; (c) α-lipoic acid; (d) coenzyme Q 10 ; (e) Vitamin E: and (i) selenomethionine, suitable for counteracting oxidative stress and use thereof are disclosed.
Claims
exact text as granted — not AI-modified1 . A combination composition comprising:
(a) L-carnitine inner salt or a pharmacologically acceptable salt thereof; (b) acetyl L-carnitine inner salt or a pharmacologically acceptable salt thereof; (c) α-lipoic acid; (d) coenzyme Q 10 ; (e) Vitamin E; and (f) selenomethionine.
2 . The composition of claim 1 in unit dosage form, comprising:
(a) 20-110 mg L-carnitine inner salt or an equivalent molar amount of a pharmacologically acceptable salt thereof; (b) 20-110 mg acetyl L-carnitine inner salt or an equivalent molar amount of a pharmacologically acceptable salt thereof; (c) 70-130 α-lipoic acid; (d) 90-110 mg coenzyme Q 10 ; (e) 5-15 mg Vitamin E; and (f) 40-60 μg selenomethionine.
3 . The composition of claim 2 , comprising:
(a) 100 mg L-carnitine inner salt; (b) 100 mg acetyl L-carnitine inner salt; (c) 100 mg α-lipoic acid; (d) 100 mg coenzyme Q 10 ; (e) 10 mg Vitamin E; and (f) 50 μg selenomethionine.
4 . The composition of claims 1 - 3 , wherein the pharmacologically acceptable salt is selected from the group comprising: chloride; bromide; iodide; aspartate, acid aspartate; citrate, acid citrate; tartrate; phosphate, acid phosphate; fumarate, acid fumarate; galactarate; glycerophosphate; glucose phosphate; lactate; maleate, acid maleate; orotate; oxalate; acid oxalate; sulphate, acid sulphate; trichloroacetate; trifluoroacetate and methane sulphonate.
5 .- 24 . (canceled)Join the waitlist — get patent alerts
Track US2005197280A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.